Literature DB >> 23906901

Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs.

G M Chambers1, V P Hoang, P J Illingworth.   

Abstract

STUDY QUESTION: What was the impact on access to assisted reproductive technology (ART) treatment by different socioeconomic status (SES) groups after the introduction of a policy that increased patient out-of-pocket costs? SUMMARY ANSWER: After the introduction of a policy that increased out-of-pocket costs in Australia, all SES groups experienced a similar percentage reduction in fresh ART cycles per 1000 women of reproductive age. Higher SES groups experienced a progressively greater reduction in absolute numbers of fresh ART cycles due to existing higher levels of utilization. WHAT IS KNOWN ALREADY: Australia has supportive public funding arrangements for ARTs. Policies that substantially increase out-of-pocket costs for ART treatment create financial barriers to access and an overall reduction in utilization. Data from the USA suggests that disparities exist in access to ART treatment based on ethnicity, education level and income. STUDY DESIGN, SIZE, DURATION: Time series analysis of utilization of ART, intrauterine insemination (IUI) and clomiphene citrate by women from varying SES groups before and after the introduction of a change in the level of public funding for ART. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Women undertaking fertility treatment in Australia between 2007 and 2010. MAIN RESULTS AND THE ROLE OF CHANCE: Women from higher SES quintiles use more ART treatment than those in lower SES quintiles, which likely reflects a greater ability to pay for treatment and a greater need for ART treatment as indicated by the trend to later childbearing. In 2009, 10.13 and 5.17 fresh ART cycles per 1000 women of reproductive age were performed in women in the highest and lowest SES quintiles respectively. In the 12 months after the introduction of a policy that increased out-of-pocket costs from ∼$1500 Australian dollars (€1000) to ∼$2500 (€1670) for a fresh IVF cycle, there was a 21-25% reduction in fresh ART cycles across all SES quintiles. The absolute reduction in fresh ART cycles in the highest SES quintile was double that in the lowest SES quintile. LIMITATIONS, REASONS FOR CAUTION: In this study, SES was based on the average relative socioeconomic advantage and disadvantage of small geographic areas, and therefore may not reflect the SES of an individual. Additionally, the policy impact was limited to the 12 months following its introduction, and may not reflect longer term trends in ART treatment. WIDER IMPLICATIONS OF THE
FINDINGS: While financial barriers are an important obstacle to equitable access to ARTs, socioeconomic differences in utilization are likely to persist in countries with supportive public funding, due in part to differences in childbearing patterns and treatment seeking behaviour. Policy makers should be informed of the impact that changes in the level of cost subsidization have on access to ART treatment by different socioeconomic groups. STUDY FUNDING/COMPETING INTEREST(S): G.M.C. receives grant support to her institution from the Australian Government, Australian Research Council (ARC) Linkage Grant No LP1002165; ARC Linkage Grant Partner Organisations are IVFAustralia, Melbourne IVF and Queensland Fertility Group. V.P.H. is employed as an Economics Research Associate on the same grant. P.J.I. is Medical Director of the IVF Clinic, IVFAustralia and has a financial interest in the parent group, Virtus. TRIAL REGISTRATION NUMBER: N/A.

Entities:  

Keywords:  assisted reproductive techniques; health economics; health policy; healthcare disparities

Mesh:

Substances:

Year:  2013        PMID: 23906901     DOI: 10.1093/humrep/det302

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

Review 1.  Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.

Authors:  Alkistis Skalkidou; Theodoros N Sergentanis; Spyros P Gialamas; Marios K Georgakis; Theodora Psaltopoulou; Marialena Trivella; Charalampos S Siristatidis; Evangelos Evangelou; Eleni Petridou
Journal:  Cochrane Database Syst Rev       Date:  2017-03-25

2.  Assisted reproductive technology use in the United States: a population assessment.

Authors:  Katherine Tierney; Yong Cai
Journal:  Fertil Steril       Date:  2019-12       Impact factor: 7.329

3.  Impact of Di-2-Ethylhexyl Phthalate Metabolites on Male Reproductive Function: a Systematic Review of Human Evidence.

Authors:  Birgit Bjerre Høyer; Virissa Lenters; Aleksander Giwercman; Bo A G Jönsson; Gunnar Toft; Karin S Hougaard; Jens Peter E Bonde; Ina Olmer Specht
Journal:  Curr Environ Health Rep       Date:  2018-03

4.  What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.

Authors:  Elena Keller; Willings Botha; Georgina M Chambers
Journal:  Appl Health Econ Health Policy       Date:  2022-09-29       Impact factor: 3.686

5.  Investigating the association between infertility and psychological distress using Australian Longitudinal Study on Women's Health (ALSWH).

Authors:  Tanmay Bagade; Kailash Thapaliya; Erica Breuer; Rashmi Kamath; Zhuoyang Li; Elizabeth Sullivan; Tazeen Majeed
Journal:  Sci Rep       Date:  2022-06-25       Impact factor: 4.996

Review 6.  Low-cost in vitro fertilization: current insights.

Authors:  Pek Joo Teoh; Abha Maheshwari
Journal:  Int J Womens Health       Date:  2014-08-21

7.  Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017.

Authors:  Hui Sun; Ting-Ting Gong; Yu-Ting Jiang; Shuang Zhang; Yu-Hong Zhao; Qi-Jun Wu
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

8.  Clinical Outcomes in High-Risk Pregnancies Due to Advanced Maternal Age.

Authors:  Rosaly Correa-de-Araujo; Sung Sug Sarah Yoon
Journal:  J Womens Health (Larchmt)       Date:  2020-11-13       Impact factor: 2.681

9.  Prevalence of infertility and help seeking among 15 000 women and men.

Authors:  J Datta; M J Palmer; C Tanton; L J Gibson; K G Jones; W Macdowall; A Glasier; P Sonnenberg; N Field; C H Mercer; A M Johnson; K Wellings
Journal:  Hum Reprod       Date:  2016-06-30       Impact factor: 6.918

10.  Household income and medical help-seeking for fertility problems among a representative population in Japan.

Authors:  Arisa Iba; Eri Maeda; Seung Chik Jwa; Ayako Yanagisawa-Sugita; Kazuki Saito; Akira Kuwahara; Hidekazu Saito; Yukihiro Terada; Osamu Ishihara; Yasuki Kobayashi
Journal:  Reprod Health       Date:  2021-08-03       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.